CN110115328A - It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof - Google Patents
It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof Download PDFInfo
- Publication number
- CN110115328A CN110115328A CN201810117425.9A CN201810117425A CN110115328A CN 110115328 A CN110115328 A CN 110115328A CN 201810117425 A CN201810117425 A CN 201810117425A CN 110115328 A CN110115328 A CN 110115328A
- Authority
- CN
- China
- Prior art keywords
- euglena
- beverage
- turmeric
- pure water
- natural inulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195620 Euglena Species 0.000 title claims abstract description 46
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 229920001202 Inulin Polymers 0.000 title claims abstract description 28
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 title claims abstract description 28
- 229940029339 inulin Drugs 0.000 title claims abstract description 28
- 235000003392 Curcuma domestica Nutrition 0.000 title claims abstract description 27
- 235000003373 curcuma longa Nutrition 0.000 title claims abstract description 27
- 235000013976 turmeric Nutrition 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 244000008991 Curcuma longa Species 0.000 title abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 15
- 238000012859 sterile filling Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 7
- 244000163122 Curcuma domestica Species 0.000 claims description 23
- 235000003599 food sweetener Nutrition 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 239000003765 sweetening agent Substances 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 235000019449 other food additives Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 230000001376 precipitating effect Effects 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- -1 galactose oligosaccharides Chemical class 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 230000001052 transient effect Effects 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 241000195493 Cryptophyta Species 0.000 claims 1
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 235000004213 low-fat Nutrition 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 150000003384 small molecules Chemical class 0.000 abstract description 2
- 238000005352 clarification Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 241000700721 Hepatitis B virus Species 0.000 description 4
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 3
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 3
- 101710142246 External core antigen Proteins 0.000 description 3
- 241000209035 Ilex Species 0.000 description 3
- 235000003332 Ilex aquifolium Nutrition 0.000 description 3
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 3
- 235000002294 Ilex volkensiana Nutrition 0.000 description 3
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 3
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229960003284 iron Drugs 0.000 description 3
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 3
- 229960001627 lamivudine Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940100243 oleanolic acid Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000234314 Zingiber Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195623 Euglenida Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003591 anti-choleraic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000440 toxicity profile Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention belongs to food processing technology fields, and in particular to a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof.The beverage is to be mixed and stirred for uniformly, by said mixture clarification, removing slag, then be made up of sterilization and sterile filling by euglena mixing magma and pure water by batching step according to formula rate.Beverage color containing euglena, turmeric and natural inulin of the invention is bright, low in calories, low fat, high protein, contains small molecule microelement, is safe and non-toxic, has the effects that anti-oxidant, liver protection protects kidney, relieves the effect of alcohol, solves constipation and quickly regain one's strength.The present invention is prepared for a kind of beverage containing euglena, turmeric and natural inulin by simple method, this beverage had not only remained herbal nutritional ingredient but also had conveniently drunk, and safety, green non-pollution, there is good healthcare function, for being daily drunk by people.
Description
Technical field
The invention belongs to food processing technology fields, and in particular to a kind of drink containing euglena, turmeric and natural inulin
Material and preparation method thereof.
Background technique
Euglena is in Euglenophyta, euglena section.Frond be it is unicellular, spindle shape or cylinder and it is slightly flat, by
Front end dolly dimple bears elongated flagellum one, moves about whereby.Flagellum base portion nearby has dots in red, can be photosensitive, claims " eyespot ".Its
Rich in the substances such as phytoprotein, lipid, acidic polysaccharose, vitamin etc., especially glycoprotein, polysaccharide and nucleic acid.With adding
Fast growth and development, enhancing immunity of organisms, the invasion for resisting exotic diseases, promotes personal injury's tissue to repair at activated lymphocyte
Again, the effects of cancer-resisting.Taking the euglena drink containing CGF for a long time can mitigate because of the huge sum of money such as the organic matters such as drug, lead, arsenic
It is poisoned caused by category, restores the function of detoxification of the internal organs such as liver,spleen,kidney, and gastric ulcer, hypertension and cardiovascular and cerebrovascular can be prevented and treated etc. slow
Property disease.
Turmeric also known as Radix Curcumae belong to Zingiber, turmeric, and effect is effect for reducing blood fat, antitumor action, anti-inflammatory and choleretic are anti-
Oxidation etc..
Natural inulin is derived from jerusalem artichoke or witloof, is a kind of natural oligofructose and a kind of soluble dietary fiber.
Its effect is to control blood lipid, the absorption for reducing blood glucose, promoting minerals, increase intestinal bifidobacteria.
Summary of the invention
The problem to be solved by the present invention is that it is pure and fresh, unique in taste while having to provide a kind of no fishy smell, smell very much again
Euglena, turmeric and beverage of natural inulin of high nutritive value and preparation method thereof.The beverage can play healthcare function and
Can long-term drinking, be the natural plant beverage that a kind of pair of human body gains everything and lose nothing.Its with anti-oxidant, liver protection shield kidney, relieve the effect of alcohol, solve
Constipation and quick the effects of regaining one's strength.
The present invention, which is that the following technical solution is employed, to be realized:
A kind of beverage containing euglena, turmeric and natural inulin, the raw material of the beverage include: euglena powder, ginger
Yellow, natural inulin, sweetener, pure water and other food additives.
Further, the mass fraction of the beverage is euglena powder 2%, turmeric 1%, natural inulin 1%, sweetener
5~15%, pure water 80%~90%, other food additives 1%.
Further, the sweetener be one of honey, galactose oligosaccharides, fructose, malic acid, vitamin C or
It is a variety of.
Further, the pH value of the pure water is 5.0~7.0.
A kind of preparation method of the beverage as described above containing euglena, turmeric and natural inulin, including following step
It is rapid:
(1) deactivation pretreatment: euglena powder, turmeric, natural inulin and pure water are respectively put into container, use is micro-
Wave sterilization microwave action 20 seconds or more of 2450 megahertzs, can will be thin when liquid temperature reaches 140 DEG C ± 2 through 3-5 kw of power
Born of the same parents bacterium is all killed;
(2) ingredient: by the resulting euglena powder of step (1), turmeric and natural inulin and sweetener and other food additives
Add agent to mix, dissolves the effective component in raw material sufficiently by heating and/or stirring means, then insoluble matter is removed, is obtained
Magma is mixed to clear euglena;Then pure water is slowly added into euglena mixing magma and stir evenly;
(3) it sterilizes: 135-150 DEG C being carried out to the resulting mixture of step (2), the sterilization of 4-7Secs UHT TRANSIENT HIGH TEMPERATURE;
(4) filling: in purification standard workshop, the resulting mixture of step (3) being subjected to sterile filling.
Further, if generated during euglena mixing magma and pure water mix again in the step (2)
Precipitating, also needs further to clarify, precipitating is filtered out.
Further, Peracetic acid sterilization is carried out to packing container in the step (4), then carries out sterile filling.
Further, the packaged form of the beverage can be plastic bottle or glass bottle.
The beneficial effects of the present invention are:
1, the beverage color of the invention containing euglena, turmeric and natural inulin is bright, low in calories, low fat, high egg
It is white, containing small molecule microelement, safe and non-toxic, have it is anti-oxidant, liver protection shield kidney, relieve the effect of alcohol, solve constipation and fast quick-recovery body
The effects of power.
2, the present invention is prepared for a kind of beverage containing euglena, turmeric and natural inulin by simple method, this
Beverage had not only remained herbal nutritional ingredient but also had conveniently drunk, and safety, green non-pollution, had good health care function
Can, for being daily drunk by people.
Specific embodiment
In order to which the object of the invention, technical solution is more clearly understood, below invention is further described in detail.
Embodiment one:
(1) deactivation pretreatment: euglena powder, turmeric, natural inulin and pure water are respectively put into container, use is micro-
Wave sterilization microwave action 20 seconds or more of 2450 megahertzs, can will be thin when liquid temperature reaches 140 DEG C ± 2 through 3-5 kw of power
Born of the same parents bacterium is all killed;
(2) ingredient: by step (1) resulting 2% euglena powder, 1% turmeric and 1% natural inulin and 5%
Sweetener and 1% other food additives mix, the sweetener be honey, galactose oligosaccharides, fructose, malic acid,
One of vitamin C is a variety of, dissolves the effective component in raw material sufficiently by heating and/or stirring means, then will
Insoluble matter removal obtains clear euglena mixing magma;Then being slowly added to 90%, pH value into euglena mixing magma is
5.0~7.0 pure water simultaneously stirs evenly;If producing precipitating again in blending process, also needs further to clarify, will precipitate
It filters out;
(3) it sterilizes: 135-150 DEG C being carried out to the resulting mixture of step (2), the sterilization of 4-7Secs UHT TRANSIENT HIGH TEMPERATURE;
(4) in purification standard workshop, the resulting mixture of step (3) is subjected to sterile filling.Wherein, to packing container into
The sterilization of row Peracetic acid, then carry out sterile filling;The packaged form of the beverage is unlimited, can be plastic bottle, is also possible to
Glass bottle.
Embodiment two:
(1) deactivation pretreatment: euglena powder, turmeric, natural inulin and pure water are respectively put into container, use is micro-
Wave sterilization microwave action 20 seconds or more of 2450 megahertzs, can will be thin when liquid temperature reaches 140 DEG C ± 2 through 3-5 kw of power
Born of the same parents bacterium is all killed;
(2) ingredient: by step (1) resulting 2% euglena powder, 1% turmeric and 1% natural inulin and 10%
Sweetener and 1% other food additives mix, the sweetener be honey, galactose oligosaccharides, fructose, malic acid,
One of vitamin C is a variety of, dissolves the effective component in raw material sufficiently by heating and/or stirring means, then will
Insoluble matter removal obtains clear euglena mixing magma;Then being slowly added to 85%, pH value into euglena mixing magma is
5.0~7.0 pure water simultaneously stirs evenly;If producing precipitating again in blending process, also needs further to clarify, will precipitate
It filters out;
(3) it sterilizes: 135-150 DEG C being carried out to the resulting mixture of step (2), the sterilization of 4-7Secs UHT TRANSIENT HIGH TEMPERATURE;
(4) in purification standard workshop, the resulting mixture of step (3) is subjected to sterile filling.Wherein, to packing container into
The sterilization of row Peracetic acid, then carry out sterile filling;The packaged form of the beverage is unlimited, can be plastic bottle, is also possible to
Glass bottle.
Embodiment three:
(1) deactivation pretreatment: euglena powder, turmeric, natural inulin and pure water are respectively put into container, use is micro-
Wave sterilization microwave action 20 seconds or more of 2450 megahertzs, can will be thin when liquid temperature reaches 140 DEG C ± 2 through 3-5 kw of power
Born of the same parents bacterium is all killed;
(2) ingredient: by step (1) resulting 2% euglena powder, 1% turmeric and 1% natural inulin and 15%
Sweetener and 1% other food additives mix, the sweetener be honey, galactose oligosaccharides, fructose, malic acid,
One of vitamin C is a variety of, dissolves the effective component in raw material sufficiently by heating and/or stirring means, then will
Insoluble matter removal obtains clear euglena mixing magma;Then being slowly added to 80%, pH value into euglena mixing magma is
5.0~7.0 pure water simultaneously stirs evenly;If producing precipitating again in blending process, also needs further to clarify, will precipitate
It filters out;
(3) it sterilizes: 135-150 DEG C being carried out to the resulting mixture of step (2), the sterilization of 4-7Secs UHT TRANSIENT HIGH TEMPERATURE;
(4) in purification standard workshop, the resulting mixture of step (3) is subjected to sterile filling.Wherein, to packing container into
The sterilization of row Peracetic acid, then carry out sterile filling;The packaged form of the beverage is unlimited, can be plastic bottle, is also possible to
Glass bottle.
1, experimental material
1.1 test medicines: euglena mixes magma.
1.2 control drugs: lamivudine, oleanolic acid, iron holly bark medicinal substances extract.
1.3 In vitro cell models: the 2.2.15 cell strain (HepG2.2.15 cell) of hepatitis B is transfected.It will
HepG2.2.15 cell inoculation (contains 10% fetal calf serum, 380 μ g/mlG418,0.03% glutamine, blueness in DMEM culture solution
Mycin and each 100 μ g/ml of streptomysin), set 5%CO2, cultivate in 37 DEG C of incubators.
Above-mentioned control drug saves backup for -20 DEG C through dimethyl sulfoxide (DMSO) after completely dissolution.
2. reagent and key instrument
Dimethyl sulfoxide (DMSO, AR), MTT (thiazolyl blue, AR), hepatitis B virus surface antigen detection kit and B-type hepatitis
Malicious e antigen detection kit is purchased from Shanghai Shiye Kehua Biotechnology Co., Ltd.
3. experimental method
The HepG2.2.15 cell of logarithmic growth phase is selected, after tryptic digestive juice digests, diluted concentration is extremely
105Cells/ml, is inoculated in 96 orifice plates, and every 200 μ L of hole after culture for 24 hours, changes the DMEM culture of the mixing magma containing euglena into
Liquid, while setting cell controls group without medical fluid culture and drug control group (including lamivudine, oleanolic acid, iron holly bark medicine
Material extract), every kind of drug sets 4 parallel holes.Replacement sample liquid is primary within every 3 days, and continuous culture 9 days takes supernatant respectively, makes
It is surveyed with hepatitis b virus s antigen diagnostic kit and hepatitis B virus e antigen diagnostic kit according to ELISA method
HBsAg and HBeAg content in cell supernatant is determined, while with above-mentioned cell strain, with the cytotoxicity of mtt assay measurement drug.
4. experiment conclusion
As shown in table 1, using HepG2.2.15 cell model, euglena mixing magma of the present invention is able to suppress second
The secretion of hepatovirus surface antigen and Hepatitis B virus e antigen has good Anti-HBV activity effect, and effective concentration is low, cytotoxicity
It is smaller.In addition, euglena mixing magma is respectively 34.8% He to the inhibiting rate of HBsAg and HBeAg in 100 μ g/ml
35.2%, positive control lamivudine and oleanolic acid and iron holly bark medicinal substances extract are better than to the inhibiting effect of HBV.
Toxicity profile of the table 1 to HepG2.2.15 cell and the inhibitory effect to HBsAg and HBeAg
Note :-: " having no overt toxicity ", which means, detects cell survival rate >=75% with mtt assay;+: " display toxicity " is meant
Cell survival rate < 75%.
Claims (8)
1. a kind of beverage containing euglena, turmeric and natural inulin, which is characterized in that the raw material of the beverage includes: a worm
Algae powder, turmeric, natural inulin, sweetener, pure water and other food additives.
2. beverage according to claim 1, which is characterized in that the mass fraction of the beverage is euglena powder 2%, ginger
Yellow 1%, natural inulin 1%, sweetener 5~15%, pure water 80%~90%, other food additives 1%.
3. beverage according to claim 1, which is characterized in that the sweetener be honey, galactose oligosaccharides, fructose,
One of malic acid, vitamin C are a variety of.
4. beverage according to claim 1, which is characterized in that the pH value of the pure water is 5.0~7.0.
5. a kind of preparation side of the beverage containing euglena, turmeric and natural inulin as described in claim 1-4 any one
Method, which comprises the following steps:
(1) deactivation pretreatment: euglena powder, turmeric, natural inulin and pure water are respectively put into container, killed using microwave
Bacterium microwave action 20 seconds or more of 2450 megahertzs, can be thin by cell when liquid temperature reaches 140 DEG C ± 2 through 3-5 kw of power
Bacterium is all killed;
(2) ingredient: by the resulting euglena powder of step (1), turmeric and natural inulin and sweetener and other food additives
It mixes, dissolves the effective component in raw material sufficiently by heating and/or stirring means, then insoluble matter is removed, is obtained clear
Clear euglena mixes magma;Then pure water is slowly added into euglena mixing magma and stir evenly;
(3) it sterilizes: 135-150 DEG C being carried out to the resulting mixture of step (2), the sterilization of 4-7Secs UHT TRANSIENT HIGH TEMPERATURE;
(4) filling: in purification standard workshop, the resulting mixture of step (3) being subjected to sterile filling.
6. preparation method according to claim 5, which is characterized in that if mixed in euglena former in the step (2)
Slurry produces precipitating again during mixing with pure water, also needs further to clarify, precipitating is filtered out.
7. preparation method according to claim 5, which is characterized in that carry out peroxide to packing container in the step (4)
Acetic acid sterilization, then carry out sterile filling.
8. preparation method according to claim 7, which is characterized in that the packaged form of the beverage is plastic bottle or glass
Glass is bottled.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810117425.9A CN110115328A (en) | 2018-02-06 | 2018-02-06 | It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810117425.9A CN110115328A (en) | 2018-02-06 | 2018-02-06 | It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110115328A true CN110115328A (en) | 2019-08-13 |
Family
ID=67519417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810117425.9A Pending CN110115328A (en) | 2018-02-06 | 2018-02-06 | It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110115328A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997824A (en) * | 2015-08-04 | 2015-10-28 | 陈志高 | Euglena health care medicine, euglena health care capsule and preparation method thereof |
CN106107267A (en) * | 2016-06-24 | 2016-11-16 | 湖北丽生堂生物科技有限公司 | A kind of composite plant beverage of relieving alcoholic intoxication and supplementary liver nutrition and preparation method thereof |
CN106360735A (en) * | 2016-10-21 | 2017-02-01 | 烟台燕园科玛健康产业有限公司 | Food composition assisting in reducing blood sugar and blood fat |
CN106387593A (en) * | 2016-09-08 | 2017-02-15 | 深圳万和制药有限公司 | Protein dietary fiber solid beverage |
WO2017075262A1 (en) * | 2015-10-28 | 2017-05-04 | Algal Scientific Corporation | Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation |
US20170290853A1 (en) * | 2016-04-12 | 2017-10-12 | Kemin Industries, Inc. | Methods to facilitate the solubilization of beta-1,3-glucan and enhance immune function and other related uses |
US20170354699A1 (en) * | 2016-06-09 | 2017-12-14 | Algaeon, Inc. | Euglena lysate composition |
-
2018
- 2018-02-06 CN CN201810117425.9A patent/CN110115328A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997824A (en) * | 2015-08-04 | 2015-10-28 | 陈志高 | Euglena health care medicine, euglena health care capsule and preparation method thereof |
WO2017075262A1 (en) * | 2015-10-28 | 2017-05-04 | Algal Scientific Corporation | Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation |
US20170290853A1 (en) * | 2016-04-12 | 2017-10-12 | Kemin Industries, Inc. | Methods to facilitate the solubilization of beta-1,3-glucan and enhance immune function and other related uses |
US20170354699A1 (en) * | 2016-06-09 | 2017-12-14 | Algaeon, Inc. | Euglena lysate composition |
CN106107267A (en) * | 2016-06-24 | 2016-11-16 | 湖北丽生堂生物科技有限公司 | A kind of composite plant beverage of relieving alcoholic intoxication and supplementary liver nutrition and preparation method thereof |
CN106387593A (en) * | 2016-09-08 | 2017-02-15 | 深圳万和制药有限公司 | Protein dietary fiber solid beverage |
CN106360735A (en) * | 2016-10-21 | 2017-02-01 | 烟台燕园科玛健康产业有限公司 | Food composition assisting in reducing blood sugar and blood fat |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW561051B (en) | Compositions of plant carbohydrates as dietary supplements | |
JP2023538664A (en) | Compositions of ginsenoside Rg3 and ginsenoside Rg5 and their pharmaceutical uses, including antitumor effects | |
CN105754000B (en) | Hijiki polysaccharide extraction process | |
CN106084087A (en) | A kind of preparation method of Fructus Trichosanthis polysaccharide | |
CN105639617A (en) | Method for comprehensively developing and applying poria cocos and new application of poria cocos | |
CN102225146B (en) | Formula and production technology of traditional Chinese medicine injection for controlling bird flu | |
CN110172106A (en) | A kind of peach gum polysaccharide iron and its application | |
CN104031156A (en) | Selfheal polysaccharide zinc chelate as well as preparation method and application thereof to anti-cancer drug | |
CN108991325A (en) | The preparation method of larch arabinogalactan solid beverage | |
CN105462793B (en) | A kind of healthy medicated wine its preparation method | |
CN110115328A (en) | It is a kind of to contain euglena, turmeric and beverage of natural inulin and preparation method thereof | |
WO2020000828A1 (en) | Gracilaria lemaneiformis polysaccharide having significant hypolipidemic activity and preparation method therefor and use thereof | |
CN101912407A (en) | Weight-reducing and lipid-lowering composition | |
CN108450941A (en) | A kind of dietary composition adjusting lipid metaboli | |
CN100484531C (en) | Donkey-hide gelatin oral preparation and its making method | |
CN110115330A (en) | It is a kind of to contain chlorella, turmeric and beverage of natural inulin and preparation method thereof | |
CN105434895A (en) | Gastrodia elata rhodiola rosea cream and preparation method thereof | |
CN100367984C (en) | Virosis-treating medicine for prawn and its preparation process | |
CN115645464B (en) | Traditional Chinese medicine composition for treating atherosclerosis and fatty liver and application thereof | |
RU2812611C1 (en) | Compositions of ginsenoside rg3 and ginsenoside rg5 and their pharmaceutical uses, including antitumor effects | |
CN101912449B (en) | Medicament for treating hepatitis and preparation technology thereof | |
CN116492372B (en) | Formula of traditional Chinese medicine for feeding lucid ganoderma to form bezoar by cattle and application of formula | |
CN112690351B (en) | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof | |
CN110115329A (en) | A kind of beverage and preparation method thereof containing Porcine HGF and soybean lecithin | |
CN107484829A (en) | A kind of DHA algal oil goat milk piece and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190813 |
|
RJ01 | Rejection of invention patent application after publication |